Despite a plaintiff’s argument that upholding the dismissal of the first hormone replacement therapy tort case to reach Pennsylvania’s highest court conflicts with succeeding case law in Pennsylvania’s HRT litigation, the state Supreme Court is leaving intact a judgment notwithstanding the verdict in favor of drugmaker Wyeth.

The Pennsylvania Supreme Court has declined to hear the first hormone replacement therapy tort case to reach the state’s highest court, leaving intact a judgment notwithstanding the verdict in favor of drugmaker Wyeth that wiped out a $3 million jury award for the plaintiff in 2007.